Display options
Share it on

Ann Pharmacol Pharm. 2017;2(15). Epub 2017 Aug 18.

Editorial: Translational Control of APP Expression for Alzheimer Disease Therapy.

Annals of pharmacology and pharmaceutics

Joanna E Pankiewicz, Martin J Sadowski

Affiliations

  1. Department of Neurology, New York University School of Medicine, New York, NY 10016.
  2. Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY 10016.
  3. Department of Psychiatry, New York University School of Medicine, New York, NY 10016.

PMID: 30288489 PMCID: PMC6168206

[No abstract available.]

Keywords: Alzheimer’s disease; amyloid precursor protein; messenger RNA; protein translation; therapy; β-amyloid

References

  1. Alzheimers Dement. 2014 Mar;10(2):e47-92 - PubMed
  2. Cold Spring Harb Perspect Med. 2012 Feb;2(2):a006288 - PubMed
  3. J Neurosci. 2002 May 1;22(9):3445-53 - PubMed
  4. Nat Rev Drug Discov. 2010 Oct;9(10):749-51 - PubMed
  5. Curr Alzheimer Res. 2006 Jul;3(3):221-7 - PubMed
  6. Acta Neuropathol Commun. 2014 Mar 31;2:36 - PubMed
  7. J Mol Neurosci. 2004;24(1):129-36 - PubMed
  8. Neuron. 2005 Dec 22;48(6):913-22 - PubMed
  9. J Neurol Neurosurg Psychiatry. 2012 Sep;83(9):894-902 - PubMed
  10. Biochem Pharmacol. 2014 Apr 15;88(4):486-94 - PubMed
  11. N Engl J Med. 2014 Jan 23;370(4):322-33 - PubMed
  12. PLoS One. 2013 Jul 31;8(7):e65978 - PubMed
  13. Exp Brain Res. 2012 Apr;217(3-4):423-34 - PubMed
  14. Front Mol Neurosci. 2017 Apr 19;10:97 - PubMed
  15. Ann Neurol. 2014 May;75(5):684-99 - PubMed

Publication Types

Grant support